Feed TENX
TE

Tenax Therapeutics, Inc. TENX · NASDAQ

$1.52 +11.76% (+$0.16)

Market cap
$40.3M
Enterprise value
-$77.7M
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/FCF
-
EV/EBITDA
-
ROIC
-60.4%
Gross margin
-
Net margin
-
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
0.92
Free float
99.8%

About the company

Tenax Therapeutics, Inc. (TENX) is a pharmaceutical company specializing in the development and commercialization of drugs for cardiovascular diseases and other serious health conditions. With high standards of scientific research and innovative treatment methods, Tenax Therapeutics is a key player in the pharmaceutical industry. Their products have the potential to improve treatment and the quality of life for patients with cardiovascular issues. The company is known for its commitment to scientific excellence and innovations in the field of pharmacy. Tenax Therapeutics, Inc. (TENX) shares could be suitable for investors looking to invest in a sector with high potential for scientific advancement and improved healthcare.

Sector

Healthcare

Industry

Biotechnology

CEO

Christopher T. Giordano

Employees

15

Headquarters

Chapel Hill

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.